Disorders Of Sexual Desire And Interest

Disorders of sexual desire or interest are the lack of or loss of sexual interest, desire, thoughts and fantasies, and the absence of a reactive desire.

In disorders of sexual desire or interest is the motivation to become sexually aroused, low or unavailable. The loss is greater than would be expected due to age and the duration of the relationship.

Disorders of sexual desire or interest are the lack of or loss of sexual interest, desire, thoughts and fantasies, and the absence of a reactive desire. In disorders of sexual desire or interest is the motivation to become sexually aroused, low or unavailable. The loss is greater than would be expected due to age and the duration of the relationship. Most psychological factors are primary (eg., Depression, anxiety, stress, relationship problems) and / or negative experiences (eg. As due to lack of sexual skills or insufficient communication of needs) causally responsible. Certain drugs such. B. particular SSRI, some antiepileptics, and ?-blockers, can just as excessive alcohol consumption reduce sexual desire. Fluctuations and changes in hormone levels (eg., During menopause, pregnancy, menstrual cycle) can affect sexual desire. For example atrophic vaginitis and hyperprolactinemia play a role. Women with disorder of sexual desire or interest tend to anxiety, low self-image and mood swings, even though no clinical mood disorder is present. The diagnosis is clinically detected (overview of sexual function and sexual disorders of women: diagnosis). Treatment education psychotherapies hormone therapy If factors that trust, respect, attraction and emotional intimacy between partners restrict the cause are to be made the couple realize that emotional intimacy is a normal condition for the sexual response of the woman and that she, with or must be strengthened without professional assistance. An explanation sufficient and appropriate stimuli can help; if necessary, the woman must remind her partner that she needs both non-physical and physically not genital and nichtpenetrativ genital stimulation. Recommendations for more intensive erotic stimuli and fantasies can help eliminate distractions; practical suggestions for improved bounds of privacy and a sense of security can help if the fear of adverse consequences (eg. as discovery, pregnancy, sexually transmitted diseases) inhibits excitability. In psychological factors that are themselves effective in the patient, psychotherapy (z. B. cognitive behavioral therapy) may be required, although the simple realization that psychological factors are important, often sufficient for a woman to change their thinking and behavior patterns. Mindfulness-based cognitive therapy (MBCT, treatment), which is usually used in women in small groups can have positive effects on arousal, orgasm and then desire and motivation. Hormonal causes require specific therapy, for. B. locally-applied estrogen in atrophic vaginitis or bromocriptine in hyperprolactinemia. Systemic estrogen therapy systemic estrogen therapy (menopause: hormone therapy), which is started in menopause or in the years after, can improve mood and help to get the dermal and genital sexual sensitivity and vaginal lubrication. These positive effects sexual desire and arousal can be increased. After menopause transdermal estrogen preparations are usually preferred; However, no studies are known, indicating which drugs available in the US in the sexual sense are most effective. Even women who have not yet had hysterectomy, get progestins or Progesteron.Testosterontherapie benefits and risks of postmenopausal testosterone replacement be further investigated. Early studies in sexually healthy postmenopausal women who had been sexually satisfying experiences before treatment and usually took estrogen showed a moderate efficacy. . Provided that interpersonal, environment-dependent and personal factors can be ruled out substitution therapy (eg with methyltestosterone may be 1.5 mg po 1 time / day or with transdermal testosterone 300 micrograms per day; there are transdermal preparations made for men used ) should be considered opinion of some experienced clinicians. However, recent studies have shown that sexually healthy postmenopausal women who are not depressed, have no relationship problems and are taking estrogen in about half the cases, no use of testosterone administration. Of a testosterone replacement could benefit women who are taking estrogen and a secondary premature ovarian failure (eg., By adrenal or Hypophysenstörung, chemotherapy, idiopathic) have. Even postmenopausal women could benefit from testosterone administration taking estrogen and no longer by the previously effective stimuli and influences can be stimulated and thereby learn sexually unsatisfactory experiences. However, these groups have not been studied, so no recommendations can be made. It’s too little about the long-term safety and efficacy of testosterone treatment known as that it could be recommended. However, it is prescribed, a comprehensive information regarding the conflicting data on the efficacy and the lack of long-term safety data must be made; next regular check-ups are necessary. At regular intervals, the levels should be calculated on free testosterone or bioavailable testosterone levels are determined (Male hypogonadism: diagnosis of primary and secondary hypogonadism); are the values ??above the normal range for pre-menopausal women, testosterone dose is reduced. Women should also be examined to hirsutism. Since the available data on the effect of testosterone is contradictory to the risk of breast cancer, the breast is examined for changes via mammography. Also, tests should be made on hyperlipidemia and impaired glucose tolerance.

Health Life Media Team

Leave a Reply